Market Estimates
Valuation Metrics
Financials
Trading Trends
RVPH News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Reviva Pharmaceuticals Holdings Inc (RVPH) stock price today?
The current price of RVPH is 0.34 USD — it has decreased -7.1 % in the last trading day.
What is Reviva Pharmaceuticals Holdings Inc (RVPH)'s business?
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
What is the price predicton of RVPH Stock?
Wall Street analysts forecast RVPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVPH is 5.14 USD with a low forecast of 2.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Reviva Pharmaceuticals Holdings Inc (RVPH)'s revenue for the last quarter?
Reviva Pharmaceuticals Holdings Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.
What is Reviva Pharmaceuticals Holdings Inc (RVPH)'s earnings per share (EPS) for the last quarter?
Reviva Pharmaceuticals Holdings Inc. EPS for the last quarter amounts to -0.06 USD, decreased -76.00 % YoY.
What changes have occurred in the market's expectations for Reviva Pharmaceuticals Holdings Inc (RVPH)'s fundamentals?
How many employees does Reviva Pharmaceuticals Holdings Inc (RVPH). have?
Reviva Pharmaceuticals Holdings Inc (RVPH) has 14 emplpoyees as of January 10 2026.
What is Reviva Pharmaceuticals Holdings Inc (RVPH) market cap?
Today RVPH has the market capitalization of 39.73M USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251229213041_7d7ba65c608fde5888298dcfefbc7a88.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251226230400_1400d75984527127335a5a50314255e3.jpg&w=384&q=75)